
Smith & Nephew plc – NYSE:SNN
Smith & Nephew stock price today
Smith & Nephew stock price monthly change
Smith & Nephew stock price quarterly change
Smith & Nephew stock price yearly change
Smith & Nephew key metrics
Market Cap | 10.74B |
Enterprise value | 13.89B |
P/E | 71.16 |
EV/Sales | 2.47 |
EV/EBITDA | 13.01 |
Price/Sales | 1.92 |
Price/Book | 4.16 |
PEG ratio | 44.47 |
EPS | 0.91 |
Revenue | 10.86B |
EBITDA | 2.69B |
Income | 487.52M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 5.41% |
Oper. margin | 13.75% |
Gross margin | 69.04% |
EBIT margin | 13.75% |
EBITDA margin | 24.77% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeSmith & Nephew stock price history
Smith & Nephew stock forecast
Smith & Nephew financial statements
$27
Potential downside: -26.78%
Analysts Price target
Financials & Ratios estimates
Jul 2022 | 2.6B | 177M | 6.81% |
---|---|---|---|
Dec 2022 | 2.74B | 48.25M | 1.76% |
Jul 2023 | 2.73B | 172M | 6.29% |
Dec 2023 | 2.79B | 90.27M | 3.23% |
Paying a dividend greater than earnings.
Payout ratio | 106.94% |
---|
2019 | 1.51% |
---|---|
2020 | 1.78% |
2021 | 2.17% |
2022 | 2.79% |
2023 | 2.75% |
Sep 2022 | 0 | 4.70B | Infinity% |
---|---|---|---|
Dec 2022 | 9966000000 | 4.70B | 47.23% |
Jun 2023 | 9844000000 | 4.61B | 46.84% |
Dec 2023 | 9987000000 | 4.77B | 47.76% |
Jul 2022 | 207M | -268M | -704M |
---|---|---|---|
Dec 2022 | 282.96M | -226.15M | -267.33M |
Jul 2023 | 113M | -182M | -86M |
Dec 2023 | 490.16M | -262.43M | -112.41M |
Smith & Nephew alternative data
Sep 2023 | 19,000 |
---|---|
Oct 2023 | 19,000 |
Nov 2023 | 19,000 |
Dec 2023 | 19,000 |
Jan 2024 | 19,000 |
Feb 2024 | 19,000 |
Mar 2024 | 18,452 |
Apr 2024 | 18,452 |
May 2024 | 18,452 |
Jun 2024 | 18,452 |
Jul 2024 | 18,452 |
Smith & Nephew other data
Patent |
---|
Grant Filling date: 14 Feb 2020 Issue date: 6 Sep 2022 |
Grant Utility: Wound treatment apparatus and method Filling date: 13 Sep 2019 Issue date: 30 Aug 2022 |
Grant Filling date: 13 Sep 2019 Issue date: 26 Jul 2022 |
Grant Filling date: 17 Aug 2018 Issue date: 5 Jul 2022 |
Grant Utility: Wound dressing Filling date: 15 Mar 2017 Issue date: 21 Jun 2022 |
Grant Filling date: 22 Dec 2016 Issue date: 21 Jun 2022 |
Grant Utility: Vacuum closure device Filling date: 20 May 2020 Issue date: 14 Jun 2022 |
Grant Utility: Wound packing Filling date: 29 Jul 2019 Issue date: 14 Jun 2022 |
Grant Utility: Wound dressing Filling date: 29 Mar 2018 Issue date: 7 Jun 2022 |
Grant Filling date: 1 Feb 2019 Issue date: 31 May 2022 |
Quarter | Transcript |
---|---|
Q4 2023 28 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 5 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 4 Aug 2023 | Q2 2023 Earnings Call Transcript |
Q4 2022 21 Feb 2023 | Q4 2022 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. Roland D. Diggelmann (1967) Chief Executive Officer & Director | $1,700,000 |
Ms. Anne-Francoise Nesmes (1972) Chief Financial Officer & Executive Director | $799,640 |
Smith & Nephew: Underappreciated Recovery With Strategic Upside
Smith & Nephew Getting No Credit For Self-Improvement Efforts ... But Should It?
Smith & Nephew: Work To Be Done But Still Long-Term Potential
Smith & Nephew: Orthopedics Growth Continues To Drive Sales Forward
Smith & Nephew: Entering New Markets But Growth Is Slow Still
Smith & Nephew: Orthopedic Franchise Finally Coming Along
Globus And NuVasive Take Spinal Fusion To A New Level
Sanara MedTech: A High Growth Micro Cap Disrupting The Wound And Skin Care Space
Smith & Nephew: Still A Buy Despite Short-Term Challenges
-
What's the price of Smith & Nephew stock today?
One share of Smith & Nephew stock can currently be purchased for approximately $36.88.
-
When is Smith & Nephew's next earnings date?
Unfortunately, Smith & Nephew's (SNN) next earnings date is currently unknown.
-
Does Smith & Nephew pay dividends?
Yes, Smith & Nephew pays dividends and its trailing 12-month yield is 3.03% with 107% payout ratio.It means that the company is paying a dividend greater than earnings. The last Smith & Nephew stock dividend of $0.28 was paid on 27 Oct 2021.
-
How much money does Smith & Nephew make?
Smith & Nephew has a market capitalization of 10.74B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 6.4% to 5.55B US dollars.
-
What is Smith & Nephew's stock symbol?
Smith & Nephew plc is traded on the NYSE under the ticker symbol "SNN".
-
What is Smith & Nephew's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Smith & Nephew?
Shares of Smith & Nephew can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Smith & Nephew's key executives?
Smith & Nephew's management team includes the following people:
- Mr. Roland D. Diggelmann Chief Executive Officer & Director(age: 58, pay: $1,700,000)
- Ms. Anne-Francoise Nesmes Chief Financial Officer & Executive Director(age: 53, pay: $799,640)
-
How many employees does Smith & Nephew have?
As Jul 2024, Smith & Nephew employs 18,452 workers.
-
When Smith & Nephew went public?
Smith & Nephew plc is publicly traded company for more then 25 years since IPO on 16 Nov 1999.
-
What is Smith & Nephew's official website?
The official website for Smith & Nephew is smith-nephew.com.
-
How can i contact Smith & Nephew?
Smith & Nephew can be reached via phone at +44 1923 477100.
-
What is Smith & Nephew stock forecast & price target?
Based on 1 Wall Street analysts` predicted price targets for Smith & Nephew in the last 12 months, the avarage price target is $27. The average price target represents a -26.78% change from the last price of $36.88.
Smith & Nephew company profile:

Smith & Nephew plc
smith-nephew.comNYSE
18,000
Medical - Devices
Healthcare
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Watford, WD18 8YE
CIK: 0000845982
ISIN: US83175M2052
CUSIP: 83175M205